BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Haga Y, Kanda T, Sasaki R, Nakamura M, Nakamoto S, Yokosuka O. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. World J Gastroenterol 2015; 21(46): 12989-12995 [PMID: 26675364 DOI: 10.3748/wjg.v21.i46.12989]
URL: https://www.wjgnet.com/1948-5182/full/v21/i46/12989.htm
Number Citing Articles
1
Eyal Shteyer, Rivka Villenchik, Mahmud Mahamid, Nidaa Nator, Rifaat Safadi. Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver DiseaseInternational Journal of Molecular Sciences 2016; 17(3): 312 doi: 10.3390/ijms17030312
2
Seul Kee Byeon, Jong Cheol Lee, Bong Chul Chung, Hong Seog Seo, Myeong Hee Moon. High-throughput and rapid quantification of lipids by nanoflow UPLC-ESI-MS/MS: application to the hepatic lipids of rabbits with nonalcoholic fatty liver diseaseAnalytical and Bioanalytical Chemistry 2016; 408(18): 4975 doi: 10.1007/s00216-016-9592-y
3
Mark Benedict, Xuchen Zhang. Non-alcoholic fatty liver disease: An expanded reviewWorld Journal of Hepatology 2017; 9(16): 715-732 doi: 10.4254/wjh.v9.i16.715
4
Yiyi Hu, Xuetao Peng, Guoping Du, Zhiqiao Zhang, Yingji Zhai, Xingbo Xiong, Xiaoliang Luo. MicroRNA-122-5p Inhibition Improves Inflammation and Oxidative Stress Damage in Dietary-Induced Non-alcoholic Fatty Liver Disease Through Targeting FOXO3Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.803445
5
S S Poul, K J Parker. Fat and fibrosis as confounding cofactors in viscoelastic measurements of the liverPhysics in Medicine & Biology 2021; 66(4): 045024 doi: 10.1088/1361-6560/abd593
6
G. Losurdo, A. Castellaneta, M. Rendina, S. Carparelli, G. Leandro, A. Di Leo. Systematic review with meta‐analysis: de novo non‐alcoholic fatty liver disease in liver‐transplanted patientsAlimentary Pharmacology & Therapeutics 2018; 47(6): 704 doi: 10.1111/apt.14521
7
Ruijie Gong, Xiaofei Lv, Fengqiong Liu. MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1Cellular & Molecular Biology Letters 2018; 23(1) doi: 10.1186/s11658-018-0083-3
8
Asmaa Elebishehy, Mohamed M. Ahmed, Badr Aldahmash, Mostafa Abdelgaber Mohamed, Aya A. Shetaia, Shaden A.M. Khalifa, Mabrouk Attia Abd Eldaim, Hesham R. El-Seedi, Nermeen Yosri. Cymbopogon schoenanthus (L) extract ameliorates high fat diet-induced obesity and dyslipidemia via reducing expression of lipogenic and thermogenic proteinsFitoterapia 2024; 175: 105897 doi: 10.1016/j.fitote.2024.105897
9
Jing Chen, Jie Liu, Ye Wang, Xuemei Hu, Feng Zhou, Yimeng Hu, Yin Yuan, Yancheng Xu. Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPARα/AdipoR2, in vivo and in vitroBiomedicine & Pharmacotherapy 2017; 91: 621 doi: 10.1016/j.biopha.2017.04.125
10
Samaneh Goorani, Mohsen Zhaleh, Majid Hajialiani, Rohallah Moradi, Mohammad Kazem Koohi, Khodabakhsh Rashidi, Mohammad Mahdi Zangeneh, Akram Zangeneh. Hepatoprotective potential of aqueous extract of Allium eriophyllum Boiss in high-fat diet-induced fatty liver diseasesComparative Clinical Pathology 2019; 28(4): 963 doi: 10.1007/s00580-018-2853-8
11
Yalei Wen, Yingjie Zhu, Caishi Zhang, Xiao Yang, Yuchen Gao, Mei Li, Hongyan Yang, Tongzheng Liu, Hui Tang. Chronic inflammation, cancer development and immunotherapyFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1040163
12
Mohammad Mahdi Zangeneh, Saman Salmani, Akram Zangeneh, Reza Khedri, Mohammad Saeid Zarei. Histopathological and biochemical effects of aqueous extract of Tragopogon graminifolius on the liver tissues of Wistar rats fed with high-fat dietComparative Clinical Pathology 2019; 28(5): 1197 doi: 10.1007/s00580-018-2828-9
13
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Mitsuhiko Moriyama, Masao Omata. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A ReviewInternational Journal of Molecular Sciences 2019; 20(6): 1358 doi: 10.3390/ijms20061358
14
Hau-Jyun Su, Jia-Horng Kao, Tai-Chung Tseng, Hung-Chih Yang, Tung-Hung Su, Pei-Jer Chen, Chun-Jen Liu. Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in TaiwanJournal of the Formosan Medical Association 2020; 119(10): 1476 doi: 10.1016/j.jfma.2020.05.027
15
Marwan SM Al-Nimer. Is COVID-19-induced liver injury different from other RNA viruses?‎World Journal of Meta-Analysis 2021; 9(2): 108-127 doi: 10.13105/wjma.v9.i2.108
16
Atsuhiro Nagasaki, Shinnichi Sakamoto, Toshiki Arai, Minami Kato, Eri Ishida, Hisako Furusho, Makiko Fujii, Takashi Takata, Mutsumi Miyauchi. Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASHJournal of Clinical Periodontology 2021; 48(10): 1367 doi: 10.1111/jcpe.13523
17
Yeon Woo Jung, Moonhyun Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim. Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis BJournal of Korean Medical Science 2020; 35(17) doi: 10.3346/jkms.2020.35.e104
18
Ming-Fang Wang, Bo Wan, Yin-Lian Wu, Jiao-Feng Huang, Yue-Yong Zhu, You-Bing Li. Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infectionWorld Journal of Gastroenterology 2021; 27(4): 336-344 doi: 10.3748/wjg.v27.i4.336
19
Tatsuo Kanda, Xia Jiang, Masato Nakamura, Yuki Haga, Reina Sasaki, Shuang Wu, Shingo Nakamoto, Fumio Imazeki, Osamu Yokosuka. Overexpression of the androgen receptor in human hepatoma cells and its effect on fatty acid metabolismOncology Letters 2017; 13(6): 4481 doi: 10.3892/ol.2017.5973
20
Koya Fujimoto, Takehiro Shiinoki, Yuki Yuasa, Yusuke Kawazoe, Masatoshi Yamane, Tatsuhiro Sera, Hidekazu Tanaka. Assessing liver fibrosis distribution through liver elasticity estimates obtained using a biomechanical model of respiratory motion with magnetic resonance elastographyPhysics in Medicine & Biology 2022; 67(15): 155005 doi: 10.1088/1361-6560/ac7d35
21
Winston Dunn, Anusha Vittal, Jie Zhao, Jianghua He, Shweta Chakraborty, Melissa Whitener, Sara Fohn, Ryan Ash, Ryan M Taylor, Mojtaba Olyaee, Jody C Olson, Nancy Todd, Beth N Floyd, Prashant Pandya, Melissa Laycock, Timothy Schmitt, Steven A Weinman. PNPLA3gene predicts clinical recovery after sustained virological response in decompensated hepatitis C cirrhosisBMJ Open Gastroenterology 2019; 6(1): e000241 doi: 10.1136/bmjgast-2018-000241
22
Shoumen Lasker, Md Mizanur Rahman, Faisal Parvez, Mushfera Zamila, Pintu Miah, Kamrun Nahar, Fariha Kabir, Surovi Binte Sharmin, Nusrat Subhan, Gias U. Ahsan, Md Ashraful Alam. High-fat diet-induced metabolic syndrome and oxidative stress in obese rats are ameliorated by yogurt supplementationScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-56538-0
23
Mehdi Afsharinasab, Maryam Mohammad-Sadeghipour, Mohammad Reza Hajizadeh, Alireza Khoshdel, Vahid Mirzaiey, Mehdi Mahmoodi. The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver diseaseSaudi Journal of Biological Sciences 2020; 27(8): 2031 doi: 10.1016/j.sjbs.2020.04.037
24
Yoshitaka Sakurai, Naoto Kubota, Toshimasa Yamauchi, Takashi Kadowaki. Role of Insulin Resistance in MAFLDInternational Journal of Molecular Sciences 2021; 22(8): 4156 doi: 10.3390/ijms22084156
25
Jun-Hyuk Lee, Hye-Sun Lee, Byoung-Kwon Lee, Yu-Jin Kwon, Ji-Won Lee. Relationship between Muscle Mass and Non-Alcoholic Fatty Liver DiseaseBiology 2021; 10(2): 122 doi: 10.3390/biology10020122
26
Gustavo Henrique De Puy e SOUZA, Luciana Diniz SILVA, Diego Alves VIEIRA, Gifone Aguiar ROCHA, Agnaldo Soares LIMA, Paula Vieira Teixeira VIDIGAL. HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND SYSTEMIC ARTERIAL HYPERTENSION ARE ASSOCIATED WITH HEPATIC NECROINFLAMMATORY ACTIVITY IN PATIENTS WITH CHRONIC HEPATITIS CArquivos de Gastroenterologia 2023; 60(3): 287 doi: 10.1590/s0004-2803.230302023-03
27
Naga Chalasani, Zobair Younossi, Joel E. Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A. Harrison, Elizabeth M. Brunt, Arun J. Sanyal. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology 2018; 67(1): 328 doi: 10.1002/hep.29367
28
Wenwu Ling, Jierong Quan, Jiangli Lin, Tingting Qiu, Jiawu Li, Qiang Lu, Changli Lu, Yan Luo. Grading fatty liver by ultrasound time-domain radiofrequency signal analysis: an <i>in vivo</i> study of ratsExperimental Animals 2018; 67(2): 249 doi: 10.1538/expanim.17-0124
29
Samaneh Goorani, Hassan Morovvati, Niloofar Seydi, Maryam Almasi, Amir Amiri-Paryan, Farzaneh Nazari, Mohammad Mahdi Zangeneh, Akram Zangeneh. Hepatoprotective and cytotoxicity properties of aqueous extract of Glycyrrhiza glabra in Wistar rats fed with high-fat dietComparative Clinical Pathology 2019; 28(5): 1305 doi: 10.1007/s00580-019-02939-6
30
Xingtian Chen, Hua Liu, Ken Chen, Yuqing Guo, Tingting Mo, Tingting Gao. Inhibition of autophagy impairs free fatty acid-induced excessive lipid accumulation in hepatocellular carcinoma and hepatic cellsJournal of Biosciences 2022; 47(2) doi: 10.1007/s12038-022-00257-8
31
Hisako Kubo, Masato Hoshi, Takuya Matsumoto, Motoko Irie, Shin Oura, Hiroko Tsutsumi, Yoji Hata, Yasuko Yamamoto, Kuniaki Saito. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed miceLipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0501-y
32
Niki Katsiki, Vasilios G. Athyros, Asterios Karagiannis. Vildagliptin: any effect on non-alcoholic fatty liver disease and serum uric acid? Re: Shelbaya S, Rakha S. Effectiveness and safety of vildagliptin and vildagliptin add-on to metformin in real-world settings in Egypt – results from the GUARD study. Curr Med Res Opin 2017;33:797-801Current Medical Research and Opinion 2017; 33(12): 2261 doi: 10.1080/03007995.2017.1333955
33
Rohallah Moradi, Majid Hajialiani, Saman Salmani, Maryam Almasi, Akram Zangeneh, Mohammad Mahdi Zangeneh. Effect of aqueous extract of Allium saralicum R.M. Fritsch on fatty liver induced by high-fat diet in Wistar ratsComparative Clinical Pathology 2019; 28(5): 1205 doi: 10.1007/s00580-018-2834-y
34
Yufeng Xing, Chuantao Zhang, Fenfen Zhai, Tianran Zhou, Xiang Cui, Zhiyi Han, Deti Peng, Guangdong Tong. Study on the Mechanism of Shugan Xiaozhi Fang on Cells with Non-alcoholic Fatty Liver DiseaseOpen Chemistry 2019; 17(1): 1328 doi: 10.1515/chem-2019-0145
35
Chien-Hao Huang, Lung-Sheng Wu, Wen-Juei Jeng, Yu-Fu Cheng, Yu-Shien Ko, I-Shyan Sheen, Chun-Yen Lin, Giuseppina Novo. In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survivalPLOS ONE 2019; 14(3): e0212770 doi: 10.1371/journal.pone.0212770
36
Shuang Wu, Tatsuo Kanda, Shingo Nakamoto, Xia Jiang, Masato Nakamura, Reina Sasaki, Yuki Haga, Hiroshi Shirasawa, Osamu Yokosuka. Cooperative effects of hepatitis B virus and TNF may play important roles in the activation of metabolic pathways through the activation of NF-κBInternational Journal of Molecular Medicine 2016; 38(2): 475 doi: 10.3892/ijmm.2016.2643
37
Stella Bernardi, Barbara Toffoli, Veronica Tisato, Fleur Bossi, Stefania Biffi, Andrea Lorenzon, Giorgio Zauli, Paola Secchiero, Bruno Fabris. TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouseClinical Science 2018; 132(1): 69 doi: 10.1042/CS20171221
38
Jun Guo, Weiwei Fang, Libo Sun, Yonggang Lu, Lin Dou, Xiuqing Huang, Weiqing Tang, Liqing Yu, Jian Li. Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturationNature Communications 2018; 9(1) doi: 10.1038/s41467-018-03072-8
39
Evanthia Tourkochristou, Stelios F. Assimakopoulos, Konstantinos Thomopoulos, Markos Marangos, Christos Triantos. NAFLD and HBV interplay - related mechanisms underlying liver disease progressionFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.965548
40
Jun-Dong Wei, Xueming Xu. Oxidative stress in Wernicke’s encephalopathyFrontiers in Aging Neuroscience 2023; 15 doi: 10.3389/fnagi.2023.1150878
41
Atsuhiro Nagasaki, Shinnichi Sakamoto, Chanbora Chea, Eri Ishida, Hisako Furusho, Makiko Fujii, Takashi Takata, Mutsumi Miyauchi. Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activationScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60904-8
42
Jia-Zhen Zhang, Jing-Jing Cai, Yao Yu, Zhi-Gang She, Hongliang Li. Nonalcoholic Fatty Liver Disease: An Update on the DiagnosisGene Expression 2019; 19(3): 187 doi: 10.3727/105221619X15553433838609
43
Samaneh Goorani, Mohsen Zhaleh, Mohammad Kazem Koohi, Niloofar Seydi, Khodabakhsh Rashidi, Mohammad Mahdi Zangeneh, Akram Zangeneh. The therapeutic potential of aqueous extract of Falcaria vulgaris in the treatment of fatty liver disease: a histopathological and biochemical approachComparative Clinical Pathology 2019; 28(4): 955 doi: 10.1007/s00580-018-2854-7
44
Li-Ting Xie, Chun-Hong Yan, Qi-Yu Zhao, Meng-Na He, Tian-An Jiang. Quantitative and noninvasive assessment of chronic liver diseases using two-dimensional shear wave elastographyWorld Journal of Gastroenterology 2018; 24(9): 957-970 doi: 10.3748/wjg.v24.i9.957
45
Anna Kakehashi, Vasily Stefanov, Naomi Ishii, Takahiro Okuno, Hideki Fujii, Kazuaki Kawai, Norifumi Kawada, Hideki Wanibuchi. Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular CarcinomasInternational Journal of Molecular Sciences 2017; 18(2): 434 doi: 10.3390/ijms18020434
46
Yang Wang, Nora Kory, Soumik BasuRay, Jonathan C. Cohen, Helen H. Hobbs. PNPLA3, CGI‐58, and Inhibition of Hepatic Triglyceride Hydrolysis in MiceHepatology 2019; 69(6): 2427 doi: 10.1002/hep.30583
47
Julia C. D’Souza, Laith R. Sultan, Stephen J. Hunt, Susan M. Schultz, Angela K. Brice, Andrew K. W. Wood, Chandra M. Sehgal. B-mode ultrasound for the assessment of hepatic fibrosis: a quantitative multiparametric analysis for a radiomics approachScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45043-z
48
Ferah TUNCEL, Aslıhan ALPASLAN DUMAN. Kronik viral hepatitli olgularda kombine non-alkolik yağlı karaciğer hastalığının sıklığı ve önemiMersin Üniversitesi Sağlık Bilimleri Dergisi 2021; 14(1): 77 doi: 10.26559/mersinsbd.883097
49
Jhon Edison Prieto-Ortiz, Nathaly Garzón Orjuela, Santiago Sánchez-Pardo, Robin Germán Prieto-Ortíz, Javier Eslava Schmalbach. Sobrevida en pacientes con cirrosis de acuerdo con su etiología. Cohorte retrospectivaRevista colombiana de Gastroenterología 2022; 37(1): 24 doi: 10.22516/25007440.703
50
Bo Zhang, Haijun Li, Dongwei Li, Hongzhi Sun, Mingqiang Li, Huawen Hu. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5pGene 2019; 700: 139 doi: 10.1016/j.gene.2019.02.096
51
Zakaria Boulahtouf, Alessia Virzì, Thomas F. Baumert, Eloi R. Verrier, Joachim Lupberger. Signaling Induced by Chronic Viral Hepatitis: Dependence and ConsequencesInternational Journal of Molecular Sciences 2022; 23(5): 2787 doi: 10.3390/ijms23052787
52
Idrees Suliman, Noha Abdelgelil, Farah Kassamali, Tarek I. Hassanein. The Effects of Hepatic Steatosis on the Natural History of HBV InfectionClinics in Liver Disease 2019; 23(3): 433 doi: 10.1016/j.cld.2019.05.001
53
Merve Sefa Sayar, Dilek Bulut, Ali Acar. Evaluation of hepatosteatosis in patients with chronic hepatitis B virus infectionArab Journal of Gastroenterology 2023; 24(1): 11 doi: 10.1016/j.ajg.2022.05.002
54
Piero Portincasa. NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient careInternal and Emergency Medicine 2023; 18(4): 993 doi: 10.1007/s11739-023-03203-0